Navigation Links
Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity
Date:10/5/2011

PARIS, Oct. 5, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today the publication of the pivotal Phase III TEMSO study with investigational once-daily oral medication teriflunomide in The New England Journal of Medicine (NEJM).  Results showed that teriflunomide at the 14mg dosage significantly reduced the annual relapse rate, reduced disability progressions and improved several magnetic resonance imaging (MRI) measures of disease activity, including new or worsening brain lesions.  Teriflunomide has a well-characterized safety profile, with a similar proportion of trial participants reporting adverse events compared to placebo.

"The TEMSO data demonstrate the effect of teriflunomide in terms of reducing relapse rates, disability progression and Magnetic Resonance Imaging (MRI) lesions," said Dr. Paul O'Connor, Director of the MS Clinic at St Michael's Hospital, Toronto, Canada and principal investigator in the TEMSO study.  "These results, sustained over two years, provide clinically meaningful data for teriflunomide."

The two-year TEMSO (TEriflunomide Multiple Sclerosis Oral) trial involved 1,088 people with relapsing forms of MS from 126 centers across 21 countries. TEMSO is the first study from a broad clinical development program that includes more than 4,000 trial participants in 36 countries and is one of the largest and broadest clinical programs of any oral MS agent under development, with five Phase III clinical trials either completed or underway.

"The publication of the teriflunomide results in the New England Journal of Medicine is an exciting milestone as we continue the development of our product," said Dr. Elias Zerhouni, President, Global Research & Development, Sanofi. "As we continue our commitment t
'/>"/>

SOURCE Sanofi; Genzyme
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger
2. Positive Phase III Data on Bayers Investigational Drug Radium-223 Chloride Show Significant Increase in Overall Survival
3. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
4. Bayer to Present New Data Evaluating Investigational Oncology Compounds at 2011 ECCO-ESMO Congress
5. Boehringer Ingelheim Broadens Its Breast Cancer Clinical Trial Program for the Investigational Compound Afatinib
6. FDA Grants Fast Track Designation to Bayers Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
7. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
8. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
9. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
10. Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Associations 71st Annual Scientific Sessions
11. Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , 1. September 2015 In nur ... 2.500 Mitarbeitern hat die SHL Group schnell weltweit ... und rapides Wachstum auf dem Markt der ... Produktivität und das Management von SHL wieder. ... SHL ist weltweit führend in Design und Herstellung ...
(Date:9/1/2015)... 31, 2015 Research and Markets ( ... "Introduction to Veterinary Pharmacovigilance (London, UK - ... This course has been designed to ... those concerned with Veterinary Pharmacovigilance. New entrants, support ... a better understanding of veterinay drug safety will ...
(Date:9/1/2015)... 1, 2015 Egalet Corporation (Nasdaq: ... company focused on discovering, developing, and commercializing innovative ...  presenting scientific data on SPRIX ® (ketorolac ... morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, ... 2015 to be held September 8 to ...
Breaking Medicine Technology:SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6
(Date:9/1/2015)... ... September 01, 2015 , ... ... Extension Vending Machine,” is still strongly maintaining her firm’s success in the hair ... tools. In her upcoming city-to-city tour, Ellis will be providing “Look and learn” ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Jerry Segal Classic to benefit the patients ... Valley Country Club in Lafayette Hill, PA. Over the past 26 years, the Classic, ... programs and services designed to support patients and their families during their time at ...
(Date:9/1/2015)... ... 01, 2015 , ... e-Spirit Inc., a leading supplier of ... Content Management System with new capabilities and enhancements designed to support the recently ... be well on their way to achieving digital transformation with less time and ...
(Date:9/1/2015)... ... , ... The FSH Society , the Massachusetts-based charity that has transformed ... the beneficiary of a collection of fundraising events this fall. From Boston to Los ... Society and further FSHD research. , The list of 2015 fall events ...
(Date:9/1/2015)... ... 01, 2015 , ... METTLER TOLEDO has announced an upcoming ... requirements“ , featuring Ed Szczesny (Quality Assurance, Rhodes Pharmaceuticals) as guest presenter. This ... , Calibration, qualification, and the appropriate level of routine testing for laboratory ...
Breaking Medicine News(10 mins):Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2
... Teen the Chance to be drawn into a ... Batman comic ... living a dual life is no easy task. Along with exercise and,eating ... after a night spent defeating Gotham City,s most evil villains., (Photo: ...
... to Retire from Company, INDIANAPOLIS, May 28 ... of its Operations, Technology and,Government Services unit based ... executive officer of that organization. Effective July 1, ... will not be replacing him,in that role., ...
... $60 million over 11 years , , WEDNESDAY, May 28 (HealthDay ... belts significantly reduces injuries to the brain, face, spine and ... rates, injury severity and hospital-acquired infections among crash patients, says ... use of air bags could reduce the use of resources ...
... A study released today reveals a cellular mechanism involved ... issue of The Journal of Neuroscience, shows that gabapentin, ... reduces alcohol intake in alcohol-dependent rats by normalizing chemical ... abuse. , The central amygdala, a part of the ...
... NEW YORK, May 28 Responding to the decline ... the past four trading days,Robin Smith, CEO, NeoStem said, ... would lead to the sudden decline in our share ... 21, 2008, we received a,private placement financing in a ...
... CHUM and MUHC migration to complete electronic records, ... Solutions, Inc. (Nasdaq: STRM ) and Emergis ... an integrated document management and,workflow solution at the ... Montreal (CHUM) and the McGill University,Health Centre (MUHC). ...
Cached Medicine News:Health News:Batman Takes on Gotham City With a Little Help From Milk 2Health News:WellPoint Announces Realignment of Operations, Technology and Government Services Unit 2Health News:Air Bags-Seat Belts Cut Injuries, Deaths, Costs 2Health News:New study reveals brain cell mechanism of alcohol dependence 2Health News:NeoStem, Inc. Comments on Recent Selling Pressure 2Health News:Streamline Health's Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients' Information - Either Scanned or Electronic 2Health News:Streamline Health's Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients' Information - Either Scanned or Electronic 3Health News:Streamline Health's Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients' Information - Either Scanned or Electronic 4Health News:Streamline Health's Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients' Information - Either Scanned or Electronic 5
Rad-5v signal extraction pulse oximeter™...
... The Avant® 4000 System with ... wired connections while ensuring reliable and ... all in a small package. The ... data to a small tabletop display, ...
The Dolphin Medical 2150 Pulse Oximeter consists of the Dolphin ONE OEM 701 Module technology, (1) extension cable, and (1) oximetry sensor to non-invasively calculate the functional saturation of ar...
Ergonomically designed, the Invacare Printing Pulse Oximeter provides fast, reliable spot-check information and documentation of SpO2 and pulse rate. It is ideal for all patients from neonate to adul...
Medicine Products: